Literature DB >> 19246245

Uniparental disomy in cancer.

Musaffe Tuna1, Sakari Knuutila, Gordon B Mills.   

Abstract

Uniparental disomy (UPD) results when both copies of a chromosome pair originate from one parent. In humans, this might result in developmental disease or cancer due to either the production of homozygosity (caused by mutated or methylated genes or by microRNA sequences) or an aberrant pattern of imprinting. Constitutional UPD is associated with meiotic errors, resulting in developmental diseases, whereas acquired UPD probably occurs as a result of a mitotic error in somatic cells, which can be an important step in cancer development and progression. This review summarizes the mechanisms underlying UPD and their emerging association with cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19246245     DOI: 10.1016/j.molmed.2009.01.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  67 in total

1.  Centrosome amplification and chromosomal instability in human and animal parthenogenetic cell lines.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Sara Maffei; Gianluca Tettamanti; Arianna Vanelli; Sara Isaac; Amir Eden; Sergio Ledda; Magda de Eguileor; Fulvio Gandolfi
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  Reciprocal uniparental disomy in yeast.

Authors:  Sabrina L Andersen; Thomas D Petes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

Review 3.  Pathogenesis and consequences of uniparental disomy in cancer.

Authors:  Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Clin Cancer Res       Date:  2011-04-25       Impact factor: 12.531

Review 4.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

Review 5.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

6.  Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

Authors:  Jill M Hagenkord; Federico A Monzon; Shera F Kash; Stan Lilleberg; Qingmei Xie; Jeffrey A Kant
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

Review 7.  Small supernumerary marker chromosomes and uniparental disomy have a story to tell.

Authors:  Thomas Liehr; Elisabeth Ewers; Ahmed B Hamid; Nadezda Kosyakova; Martin Voigt; Anja Weise; Marina Manvelyan
Journal:  J Histochem Cytochem       Date:  2011-06-14       Impact factor: 2.479

8.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

9.  Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.

Authors:  Fernando P G Silva; Inês Almeida; Bruno Morolli; Geeske Brouwer-Mandema; Hans Wessels; Rolf Vossen; Harry Vrieling; Erik W A Marijt; Peter J M Valk; Hanneke C Kluin-Nelemans; Wolfgang R Sperr; Wolf-Dieter Ludwig; Micheline Giphart-Gassler
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

10.  Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells.

Authors:  Junichi Soh; Naoki Okumura; William W Lockwood; Hiromasa Yamamoto; Hisayuki Shigematsu; Wei Zhang; Raj Chari; David S Shames; Ximing Tang; Calum MacAulay; Marileila Varella-Garcia; Tõnu Vooder; Ignacio I Wistuba; Stephen Lam; Rolf Brekken; Shinichi Toyooka; John D Minna; Wan L Lam; Adi F Gazdar
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.